18 employees
INmune Bio is developing therapies that harness the patient’s immune system to treat cancer.
2015
$8.2M
from 2 investors over 2 rounds
INmune Bio Inc. raised $7M on June 10, 2019
Investors: Toucan Capital
INmune Bio Inc. raised $8.2M on February 7, 2019
Investors: Alector